Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nerve block may beat standard shots for back pain relief

NCT ID NCT05565053

Symptom relief Sponsor: Istanbul University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tested whether a nerve block (erector spinae plane block) works better than standard trigger point injections for easing myofascial back pain. 60 adults with myofascial pain syndrome received one of the two procedures. Researchers measured pain levels using a standard pain scale to compare how well each treatment worked.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
nerve block (erector spinae plane block) and trigger point injection
What this could lead to
If the nerve block works better, it could offer a longer-lasting pain relief option for people with myofascial back pain.
What could go wrong
This is a small, completed study with only 60 participants. Results may not apply to everyone, and the nerve block is a procedure with its own risks like bleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Jul 2021

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Get a myofascial pain syndrome diagnosis * No invasive procedure for myofascial pain syndrome in the last 1 month * Signing the informed consent form Exclusion Criteria: * Cervical disc herniation * Neck/shoulder, thoracal trauma or operation history * Malignancy * Kyphoscoliosis * Inflammatory diseases (Rheumatoid arthritis, ankylosing spondylitis...) * Congenital vertebral anomalies * Pregnancy * Mental, psychogenic disorder * Hematological diseases that cause bleeding and coagulation disorders * Use of antiplatelet, anticoagulant and drugs that cause bleeding tendency * Severe systemic infection such as sepsis and local infection at the intervention site * Having an allergy to any of the drugs to be used

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myofascial pain syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

myofascial pain syndrome Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Myofascial pain syndrome

Contacts and locations

Locations

  • Istanbul University Istanbul Faculty of Medicine

    Istanbul, 34104, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.